Journal of the American College of Cardiology, ISSN 0735-1097, 03/2018, Volume 71, Issue 11, pp. 1231 - 1242
Contrasting evidence exists on the comparative efficacy and safety of bivalirudin and unfractionated heparin (UFH) in relation to the planned use of...
heparin | MATRIX | GP IIb/IIIa inhibitor | acute coronary syndrome | bivalirudin | TRIAL | IIB/IIIA INHIBITORS | ACUTE MYOCARDIAL-INFARCTION | PRIMARY PCI | INTERVENTION | CARDIAC & CARDIOVASCULAR SYSTEMS | Postoperative Complications - etiology | Humans | Middle Aged | Heparin - administration & dosage | Male | Hemorrhage - prevention & control | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Percutaneous Coronary Intervention - methods | Female | Electrocardiography - methods | Hematologic Agents - adverse effects | Coronary Artery Bypass - methods | Peptide Fragments - administration & dosage | Treatment Outcome | Recombinant Proteins - administration & dosage | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Acute Coronary Syndrome - drug therapy | Coronary Artery Bypass - adverse effects | Hematologic Agents - classification | Intraoperative Care - methods | Hirudins - adverse effects | Acute Coronary Syndrome - diagnosis | Acute Coronary Syndrome - surgery | Aged | Peptide Fragments - adverse effects | Hematologic Agents - administration & dosage | Hemorrhage - chemically induced | Percutaneous Coronary Intervention - adverse effects | Postoperative Complications - classification | Coronary heart disease | Analysis | Heparin | Myocardial infarction | Blood transfusions | Surgical implants | Transfusion | Heart attacks | Bleeding | Consortia | Ischemia | Surgery | Implants | Bailout | Electrocardiography | Safety | Thromboembolism | Cerebral infarction | Stroke | Sensitivity analysis | Medical imaging | Complications | Mortality | Glycoprotein | Patients | Thrombosis | Infarction | Acute coronary syndromes
heparin | MATRIX | GP IIb/IIIa inhibitor | acute coronary syndrome | bivalirudin | TRIAL | IIB/IIIA INHIBITORS | ACUTE MYOCARDIAL-INFARCTION | PRIMARY PCI | INTERVENTION | CARDIAC & CARDIOVASCULAR SYSTEMS | Postoperative Complications - etiology | Humans | Middle Aged | Heparin - administration & dosage | Male | Hemorrhage - prevention & control | Recombinant Proteins - adverse effects | Heparin - adverse effects | Hirudins - administration & dosage | Percutaneous Coronary Intervention - methods | Female | Electrocardiography - methods | Hematologic Agents - adverse effects | Coronary Artery Bypass - methods | Peptide Fragments - administration & dosage | Treatment Outcome | Recombinant Proteins - administration & dosage | Platelet Glycoprotein GPIIb-IIIa Complex - antagonists & inhibitors | Acute Coronary Syndrome - drug therapy | Coronary Artery Bypass - adverse effects | Hematologic Agents - classification | Intraoperative Care - methods | Hirudins - adverse effects | Acute Coronary Syndrome - diagnosis | Acute Coronary Syndrome - surgery | Aged | Peptide Fragments - adverse effects | Hematologic Agents - administration & dosage | Hemorrhage - chemically induced | Percutaneous Coronary Intervention - adverse effects | Postoperative Complications - classification | Coronary heart disease | Analysis | Heparin | Myocardial infarction | Blood transfusions | Surgical implants | Transfusion | Heart attacks | Bleeding | Consortia | Ischemia | Surgery | Implants | Bailout | Electrocardiography | Safety | Thromboembolism | Cerebral infarction | Stroke | Sensitivity analysis | Medical imaging | Complications | Mortality | Glycoprotein | Patients | Thrombosis | Infarction | Acute coronary syndromes
Journal Article
Journal of the American College of Cardiology, ISSN 0735-1097, 05/2017, Volume 69, Issue 21, pp. 2592 - 2603
Background It remains unclear whether radial access (RA), compared with femoral access (FA), mitigates the risk of acute kidney injury (AKI). Objectives The...
coronary intervention | creatinine | bleeding | estimated glomerular filtration rate | ST-segment elevation | CROSS BLUE-SHIELD | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | INTERVENTIONS | IMPACT | CARDIAC-CATHETERIZATION | CONTRAST-INDUCED NEPHROPATHY | VASCULAR ACCESS | INSIGHTS | Coronary heart disease | Analysis | Myocardial infarction | Heart | End-stage renal disease | Femur | Transfusion | Angioplasty | Hematocrit | Blood | Risk factors | Incidence | Elevation | Motivation | Surgery | Anticoagulants | Anemia | Regression analysis | Appendix | Inhibitors | Nephropathy | Embolization | Dialysis | Acute coronary syndromes | Health risk assessment | Circulation | Kidney transplantation | Intervention | Populations | Attitude control | Angiography | Prophylaxis | Clinical trials | Blood transfusion | Bleeding | Guidelines | Reduction | Risk assessment | Calcium-binding protein | Mathematical models | Lesions | Cardiology | Contrast media | Creatinine | Kidneys | Statistical analysis | Catheterization | Complications | Blood cells | Health risks | Management | Statistics | Cholesterol | Kidney diseases
coronary intervention | creatinine | bleeding | estimated glomerular filtration rate | ST-segment elevation | CROSS BLUE-SHIELD | CARDIAC & CARDIOVASCULAR SYSTEMS | RISK-FACTORS | INTERVENTIONS | IMPACT | CARDIAC-CATHETERIZATION | CONTRAST-INDUCED NEPHROPATHY | VASCULAR ACCESS | INSIGHTS | Coronary heart disease | Analysis | Myocardial infarction | Heart | End-stage renal disease | Femur | Transfusion | Angioplasty | Hematocrit | Blood | Risk factors | Incidence | Elevation | Motivation | Surgery | Anticoagulants | Anemia | Regression analysis | Appendix | Inhibitors | Nephropathy | Embolization | Dialysis | Acute coronary syndromes | Health risk assessment | Circulation | Kidney transplantation | Intervention | Populations | Attitude control | Angiography | Prophylaxis | Clinical trials | Blood transfusion | Bleeding | Guidelines | Reduction | Risk assessment | Calcium-binding protein | Mathematical models | Lesions | Cardiology | Contrast media | Creatinine | Kidneys | Statistical analysis | Catheterization | Complications | Blood cells | Health risks | Management | Statistics | Cholesterol | Kidney diseases
Journal Article
Jacc. Cardiovascular Interventions, ISSN 1936-8798, 2018, Volume 11, Issue 16, pp. 1576 - 1586
OBJECTIVES: The study sought to assess whether treatment with ticagrelor, as compared with prasugrel and clopidogrel, improves endothelium-dependent dilation...
adenosine | endothelial function | inhibitors | prasugrel | ticagrelor | P2Y | CARDIAC & CARDIOVASCULAR SYSTEMS | PLATELET-AGGREGATION | HUMANS | ACUTE CORONARY SYNDROME | TRIAL | INHIBITION | P2Y inhibitors | DISEASE | PERIPHERAL ARTERIAL TONOMETRY | P2Y RECEPTOR | PLASMA-CONCENTRATION
adenosine | endothelial function | inhibitors | prasugrel | ticagrelor | P2Y | CARDIAC & CARDIOVASCULAR SYSTEMS | PLATELET-AGGREGATION | HUMANS | ACUTE CORONARY SYNDROME | TRIAL | INHIBITION | P2Y inhibitors | DISEASE | PERIPHERAL ARTERIAL TONOMETRY | P2Y RECEPTOR | PLASMA-CONCENTRATION
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 01/2018, Volume 11, Issue 1, pp. 36 - 50
Objectives This study sought to assess whether transradial access (TRA) compared with transfemoral access (TFA) is associated with consistent outcomes in male...
MATRIX | female | radial access | femoral access | acute coronary syndrome(s) | male | MORTALITY | CATHETERIZATION | CARDIAC & CARDIOVASCULAR SYSTEMS | STRATEGY | BLEEDING COMPLICATIONS | WOMEN | ACUTE MYOCARDIAL-INFARCTION | POOLED ANALYSIS | INTERVENTION | CLINICAL-OUTCOMES | INSIGHTS
MATRIX | female | radial access | femoral access | acute coronary syndrome(s) | male | MORTALITY | CATHETERIZATION | CARDIAC & CARDIOVASCULAR SYSTEMS | STRATEGY | BLEEDING COMPLICATIONS | WOMEN | ACUTE MYOCARDIAL-INFARCTION | POOLED ANALYSIS | INTERVENTION | CLINICAL-OUTCOMES | INSIGHTS
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 08/2018, Volume 11, Issue 16, pp. 1576 - 1586
The study sought to assess whether treatment with ticagrelor, as compared with prasugrel and clopidogrel, improves endothelium-dependent dilation throughout...
adenosine | endothelial function | P2Y12 inhibitors | prasugrel | ticagrelor
adenosine | endothelial function | P2Y12 inhibitors | prasugrel | ticagrelor
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 2018, Volume 11, Issue 16, pp. 1576 - 1586
Objectives: The study sought to assess whether treatment with ticagrelor, as compared with prasugrel and clopidogrel, improves endothelium-dependent dilation...
adenosine | endothelial function | P2Y12 inhibitors | prasugrel | ticagrelor | d_article_not_yet_freely_accessible
adenosine | endothelial function | P2Y12 inhibitors | prasugrel | ticagrelor | d_article_not_yet_freely_accessible
Journal Article
JACC: Cardiovascular Interventions, ISSN 1936-8798, 01/2018, Volume 11, Issue 1, pp. 36 - 50
This study sought to assess whether transradial access (TRA) compared with transfemoral access (TFA) is associated with consistent outcomes in male and female...
MATRIX | radial access | female | femoral access | acute coronary syndrome(s) | male
MATRIX | radial access | female | femoral access | acute coronary syndrome(s) | male
Journal Article
JACC (Journal of the American College of Cardiology), ISSN 0735-1097, 2017, Volume 69, Issue 21, pp. 2592 - 2603
Abstract Background It remains unclear whether radial access (RA), compared with femoral access (FA), mitigates the risk of acute kidney injury (AKI)....
Cardiovascular | Internal Medicine | coronary intervention | creatinine | bleeding | estimated glomerular filtration rate | ST-segment elevation
Cardiovascular | Internal Medicine | coronary intervention | creatinine | bleeding | estimated glomerular filtration rate | ST-segment elevation
Journal Article
Journal of Health and Social Sciences, ISSN 2499-2240, 03/2017, Volume 2, Issue 1, pp. 47 - 64
Introduction: Look alike/sound alike (LASA) drugs errors can take place in hospital wards, and they can place patients at risk for adverse events and death....
LASA drugs | risk management | patient safety | FMEA | drug safety | risk assessement | risk management; risk assessment; LASA drugs; drug safety; FMEA; patient safety
LASA drugs | risk management | patient safety | FMEA | drug safety | risk assessement | risk management; risk assessment; LASA drugs; drug safety; FMEA; patient safety
Journal Article
International Journal of Clinical Pharmacy, ISSN 2210-7703, 4/2014, Volume 36, Issue 2, pp. 233 - 242
Background The implementation of preventive measures of look-alike/sound-alike drugs incidents has given rise to a fundamental rule in Clinical Risk...
Look alike/sound alike | Medicine & Public Health | Drug names | Pharmacy | Patient safety | Internal Medicine | Medication errors | Risk management | CONFUSION | SAFETY | LOOK-ALIKE | SOUND-ALIKE | PHARMACOLOGY & PHARMACY | MEDICINES | Drug Labeling | Humans | Medication Errors - prevention & control | Drugs | Clinical trials | Medical errors | Drug therapy
Look alike/sound alike | Medicine & Public Health | Drug names | Pharmacy | Patient safety | Internal Medicine | Medication errors | Risk management | CONFUSION | SAFETY | LOOK-ALIKE | SOUND-ALIKE | PHARMACOLOGY & PHARMACY | MEDICINES | Drug Labeling | Humans | Medication Errors - prevention & control | Drugs | Clinical trials | Medical errors | Drug therapy
Journal Article
No results were found for your search.
Cannot display more than 1000 results, please narrow the terms of your search.